Literature DB >> 19721051

Bone sarcomas arising in patients with neurofibromatosis type 1.

M Chowdhry1, C Hughes, R J Grimer, V Sumathi, S Wilson, L Jeys.   

Abstract

We identified eight patients of 2900 with a primary malignant bone tumour who had coexisting neurofibromatosis type 1. This was a much higher incidence than would be expected by chance. The patients had a mean age of 22.4 years (9 to 54): five were male. Two patients subsequently developed a second bone sarcoma, one of which was radiation induced. Four of the primary tumours were osteosarcomas, four were spindle-cell sarcomas and one a Ewing's sarcoma. All the patients were treated with chemotherapy and surgery: six of the eight appear to be cured. This study suggests a possible relationship between neurofibromatosis type 1 and the development of a bone sarcoma, the increased risk being estimated at eight times that of the normal population. We recommend that further research into this possible link should be considered.

Entities:  

Mesh:

Year:  2009        PMID: 19721051     DOI: 10.1302/0301-620X.91B9.22299

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  6 in total

1.  A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis.

Authors:  Branden S Moriarity; George M Otto; Eric P Rahrmann; Susan K Rathe; Natalie K Wolf; Madison T Weg; Luke A Manlove; Rebecca S LaRue; Nuri A Temiz; Sam D Molyneux; Kwangmin Choi; Kevin J Holly; Aaron L Sarver; Milcah C Scott; Colleen L Forster; Jaime F Modiano; Chand Khanna; Stephen M Hewitt; Rama Khokha; Yi Yang; Richard Gorlick; Michael A Dyer; David A Largaespada
Journal:  Nat Genet       Date:  2015-05-11       Impact factor: 38.330

2.  Tumor and Constitutional Sequencing for Neurofibromatosis Type 1.

Authors:  Schuyler Tong; W Patrick Devine; Joseph T Shieh
Journal:  JCO Precis Oncol       Date:  2022-05

3.  The ARF tumor suppressor regulates bone remodeling and osteosarcoma development in mice.

Authors:  Daniel A Rauch; Michelle A Hurchla; John C Harding; Hongju Deng; Lauren K Shea; Mark C Eagleton; Stefan Niewiesk; Michael D Lairmore; David Piwnica-Worms; Thomas J Rosol; Jason D Weber; Lee Ratner; Katherine N Weilbaecher
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

4.  Epithelioid sarcoma associated with neurofibromatosis type I.

Authors:  Sung Oh Hwang; Soo Hyang Lee; Han Byul Lee
Journal:  Arch Craniofac Surg       Date:  2020-02-20

5.  Ewing sarcoma in a child with neurofibromatosis type 1.

Authors:  Karen S Fernandez; Michelle L Turski; Avanthi Tayi Shah; Boris C Bastian; Andrew Horvai; Steven Hardee; E Alejandro Sweet-Cordero
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-10-23

6.  Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020.

Authors:  Jace P Landry; Kelsey L Schertz; Yi-Ju Chiang; Angela D Bhalla; Min Yi; Emily Z Keung; Christopher P Scally; Barry W Feig; Kelly K Hunt; Christina L Roland; Ashleigh Guadagnolo; Andrew J Bishop; Alexander J Lazar; John M Slopis; Ian E McCutcheon; Keila E Torres
Journal:  JAMA Netw Open       Date:  2021-03-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.